4070 super ph

New Delhi, Dec 26 (PTI) India's sports fraternity on Thursday joined the nation in mourning the demise of two-time former Prime Minister Dr Manmohan Singh, paying homage to his "calm leadership and wisdom" in stirring condolence messages. Singh, 92, died at the All India Institute of Medical Sciences (AIIMS) here after losing consciousness at his home owing to age-related ailments. "Sad news of the passing of Dr. Manmohan Singh Ji. A visionary leader and a true statesman who worked tirelessly for India's progress. His wisdom and humility will always be remembered. My heartfelt condolences to his loved ones," World Cup-winning former cricketer Yuvraj Singh posted on X. Similar sentiments were expressed by his former teammate and Aam Aadmi Party's Rajya Sabha member Harbhajan Singh, who described Singh as a thorough gentleman and visionary leader. "What truly set him apart was his calm and steady leadership in times of crisis, his ability to navigate complex political landscapes, and his unwavering belief in India's potential," he wrote. It was during Singh's second tenure that India hosted the 2010 Commonwealth Games in the national capital. It was the first international multi-sport extravaganza to be held in the country after the 1982 Asian Games, also hosted by Delhi. Former wrestler Vinesh Phogat, who is now a Congress MLA in Haryana, called Singh a man of "extraordinary wisdom, simplicity and vision." "Dr. Manmohan Singh was not just a Prime Minister, but he was a thinker, economist and a true patriot. His calm leadership style and economic vision gave the country a new direction, from the 1991 economic reforms to establishing India's reputation on the global stage. "There was depth in his humility and wisdom in his every word. His services and contributions to the country will always be remembered. You will always live in our hearts, Sir," she wrote in her emotional tribute on social media. Former cricketers Virender Sehwag and VVS Laxman and ex-women's hockey team captain Rani Rampal were also among those who expressed their sadness at his death. Before serving as Prime Minister from 2004 to 2014, Singh was finance minister in the P V Narasimha Rao-led government and was the brain behind the economic reforms of 1991 that marked the beginning of liberalisation in the country. Widely respected for his intellect and grace in public life, Singh had retired from active politics in April this year after over a three-decade run as a Rajya Saha MP. (This story has not been edited by THE WEEK and is auto-generated from PTI)WALTHAM, Mass., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that, effective December 1, 2024, the company granted non-qualified stock options to purchase 8,400 shares of its common stock to one new employee under Xilio Therapeutics’ 2022 Inducement Stock Incentive Plan. The stock options have an exercise price of $1.09 per share, which is equal to the closing price of the company’s common stock on November 29, 2024. Each stock option will have a ten-year term and will vest as to 25% of the shares underlying the stock option on the first anniversary following commencement of employment, and the remaining 75% of the shares underlying each stock option will vest in 36 equal monthly installments thereafter, subject to continued service with the company or any of its subsidiaries through each applicable vesting date. The stock options are subject to the terms and conditions of Xilio Therapeutics’ 2022 Inducement Stock Incentive Plan, as well as the terms and conditions of the stock option agreement covering the grant and were made as an inducement material to the individual entering into employment with the company in accordance with Nasdaq Listing Rule 5635(c)(4). About Xilio Therapeutics Xilio Therapeutics is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines, antibodies, bispecifics and immune cell engagers. Learn more by visiting www.xiliotx.com and follow us on LinkedIn ( Xilio Therapeutics, Inc .). This press release contains hyperlinks to information that is not deemed to be incorporated by reference in this press release. Investor and Media Contact: Scott Young Vice President, Investor Relations and Corporate Communications investors@xiliotx.com
PHILADELPHIA and PERTH, Australia , Dec. 23, 2024 /PRNewswire/ -- Arcadium Lithium plc (NYSE: ALTM, ASX: LTM, "Arcadium Lithium"), a leading global lithium chemicals producer, today announced that it has obtained all requisite shareholder approvals in connection with the proposed acquisition by Rio Tinto previously announced on October 9 , 2024. "Today's vote of support by our shareholders confirms our shared belief that with Rio Tinto, we will be a stronger global leader in lithium chemicals production. Together, we enhance our capabilities to successfully develop and operate our assets while supporting the clean energy transition. We are confident that this transaction will provide future benefit to our customers, employees and the communities in which we operate, and I am excited by the path ahead," said Paul Graves , president and chief executive officer of Arcadium Lithium. The final voting results of Arcadium Lithium's special meetings will be filed with the Securities and Exchange Commission in a Form 8-K and will also be available at https://ir.arcadiumlithium.com . Regulatory Update As of this release, merger control clearance has been satisfied or waived in Australia , Canada , China , the United Kingdom and the United States (Hart-Scott-Rodino Antitrust Improvements Act of 1976). Additionally, investment screening approval has been satisfied in the United Kingdom . The proposed transaction is still expected to close in mid-2025, subject to the receipt of remaining regulatory approvals and other closing conditions. Arcadium Lithium Contacts Investors: Daniel Rosen +1 215 299 6208 daniel.rosen@arcadiumlithium.com Phoebe Lee +61 413 557 780 phoebe.lee@arcadiumlithium.com Media: Karen Vizental +54 9 114 414 4702 karen.vizental@arcadiumlithium.com About Arcadium Lithium Arcadium Lithium is a leading global lithium chemicals producer committed to safely and responsibly harnessing the power of lithium to improve people's lives and accelerate the transition to a clean energy future. We collaborate with our customers to drive innovation and power a more sustainable world in which lithium enables exciting possibilities for renewable energy, electric transportation and modern life. Arcadium Lithium is vertically integrated, with industry-leading capabilities across lithium extraction processes, including hard-rock mining, conventional brine extraction and direct lithium extraction (DLE), and in lithium chemicals manufacturing for high performance applications. We have operations around the world, with facilities and projects in Argentina , Australia , Canada , China , Japan , the United Kingdom and the United States . For more information, please visit us at www.ArcadiumLithium.com . Important Information and Legal Disclaimer: Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: Certain statements in this news release are forward-looking statements. In some cases, we have identified forward-looking statements by such words or phrases as "will likely result," "is confident that," "expect," "expects," "should," "could," "may," "will continue to," "believe," "believes," "anticipates," "predicts," "forecasts," "estimates," "projects," "potential," "intends" or similar expressions identifying "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including the negative of those words and phrases. Such forward-looking statements are based on our current views and assumptions regarding future events, future business conditions and the outlook for Arcadium Lithium based on currently available information. There are important factors that could cause Arcadium Lithium's actual results, level of activity, performance or achievements to differ materially from the results, level of activity, performance or achievements expressed or implied by the forward-looking statements, including the completion of the transaction on anticipated terms and timing, including obtaining required regulatory approvals, and the satisfaction of other conditions to the completion of the transaction; potential litigation relating to the transaction that could be instituted by or against Arcadium Lithium or its affiliates, directors or officers, including the effects of any outcomes related thereto; the risk that disruptions from the transaction will harm Arcadium Lithium's business, including current plans and operations; the ability of Arcadium Lithium to retain and hire key personnel; potential adverse reactions or changes to business or governmental relationships resulting from the announcement or completion of the transaction; certain restrictions during the pendency of the transaction that may impact Arcadium Lithium's ability to pursue certain business opportunities or strategic transactions; significant transaction costs associated with the transaction; the possibility that the transaction may be more expensive to complete than anticipated, including as a result of unexpected factors or events; the occurrence of any event, change or other circumstance that could give rise to the termination of the transaction, including in circumstances requiring Arcadium Lithium to pay a termination fee or other expenses; competitive responses to the transaction; the supply and demand in the market for our products as well as pricing for lithium and high-performance lithium compounds; our ability to realize the anticipated benefits of the integration of the businesses of Livent and Allkem or of any future acquisitions; our ability to acquire or develop additional reserves that are economically viable; the existence, availability and profitability of mineral resources and mineral and ore reserves; the success of our production expansion efforts, research and development efforts and the development of our facilities; our ability to retain existing customers; the competition that we face in our business; the development and adoption of new battery technologies; additional funding or capital that may be required for our operations and expansion plans; political, financial and operational risks that our lithium extraction and production operations, particularly in Argentina , expose us to; physical and other risks that our operations and suppliers are subject to; our ability to satisfy customer qualification processes or customer or government quality standards; global economic conditions, including inflation, fluctuations in the price of energy and certain raw materials; the ability of our joint ventures, affiliated entities and contract manufacturers to operate according to their business plans and to fulfill their obligations; severe weather events and the effects of climate change; extensive and dynamic environmental and other laws and regulations; our ability to obtain and comply with required licenses, permits and other approvals; and other factors described under the caption entitled "Risk Factors" in Arcadium Lithium's 2023 Form 10-K filed with the SEC on February 29, 2024 , as well as Arcadium Lithium's other SEC filings and public communications. Although Arcadium Lithium believes the expectations reflected in the forward-looking statements are reasonable, Arcadium Lithium cannot guarantee future results, level of activity, performance or achievements. Moreover, neither Arcadium Lithium nor any other person assumes responsibility for the accuracy and completeness of any of these forward-looking statements. Arcadium Lithium is under no duty to update any of these forward-looking statements after the date of this news release to conform its prior statements to actual results or revised expectations . View original content to download multimedia: https://www.prnewswire.com/news-releases/arcadium-lithium-announces-shareholder-approval-of-proposed-rio-tinto-transaction-and-provides-regulatory-update-302338409.html SOURCE Arcadium Lithium PLCBritain’s lost knocker uppers | Holy Cow! History
NoneLouisville scores 52 second-half points to race past No. 14 Indiana 89-61 in the Battle 4 Atlantis
Saquon Barkley and the Philadelphia Eagles make their second-to-last road trip of the regular season Sunday to face Derrick Henry and the Baltimore Ravens. The NFC East-leading Eagles (9-2) have won seven in a row and play four of their final six games in Philadelphia, traveling only about 125 miles to visit the Ravens (8-4) this weekend and the Washington Commanders in Week 16. Sunday's game features the NFL's two leading rushers. Barkley (1,392 yards) and Henry (1,325) are far ahead of Green Bay's Josh Jacobs (944) in third place. Henry leads the league with 13 rushing touchdowns. Barkley (10) is tied for fourth and Philadelphia quarterback Jalen Hurts (11) tied for second. The matchup also features two of the top candidates for Most Valuable Player honors entering Week 13 in Barkley and Baltimore quarterback Lamar Jackson, who won his second MVP award last season. Their competition includes quarterbacks Josh Allen of Buffalo and Jared Goff of Detroit, with Allen widely considered the favorite. "Lamar Jackson and Derrick Henry are phenomenal football players that help their team win football games, and Jalen Hurts and Saquon Barkley are phenomenal football players that help their team win football games," Eagles coach Nick Sirianni said. "Excited about the opportunity this week because it's our next one. It will be a really good opponent, really well coached, good players, good atmosphere that will be there. Excited about the opportunity this week. And we're going to have to be on it against a really good team." The showdown at M&T Bank Stadium also pits Baltimore's No. 1 offense (426.7 yards per game) and No. 2 scoring offense (30.3 points per game) against Philadelphia's No. 1 defense (274.6) and No. 6 scoring defense (18.1). The Eagles have held seven consecutive opponents to under 300 total yards, while the Ravens have gained at least 329 yards of offense in all 11 games. Philadelphia is coming off a 37-20 road win over the Los Angeles Rams on Sunday night in which Barkley smashed the franchise record with 255 rushing yards. Baltimore also earned a prime-time win in Los Angeles, defeating the Chargers 30-23 in the "Harbaugh Bowl" on Monday night behind Jackson's three touchdowns (two passing, one rushing). Jackson said he's looking forward to the Barkley and Henry show. "I've known Saquon from high school. We were in the all-star game together and he jumped over somebody's head," Jackson recalled Wednesday. "So I've pretty much seen him before I even got to the league, college, anything. I've been knowing about Saquon, but Derrick Henry -- King Henry -- I'm with him every day and I'm seeing what he's capable of, so it's going to be a great matchup." Ravens linebacker Roquan Smith practiced Wednesday after sitting out Monday with a hamstring issue. Nose tackle Michael Pierce (calf) was designated to return from injured reserve. Tight end Charlie Kolar (broken arm) is out for several weeks and cornerback Arthur Maulet (calf) did not practice. The Eagles lost veteran defensive end Brandon Graham to a season-ending triceps injury Sunday. Wideout DeVonta Smith (hamstring) missed the win over the Rams and did not practice Wednesday. Neither did cornerbacks Darius Slay (concussion) or Kelee Ringo (calf). Philadelphia is 5-1 away from home this season -- 6-1 if you count their season-opening "home" victory against the Packers in Sao Paulo, Brazil. Baltimore is 4-1 at home. The Ravens hold a 3-2-1 lead in the series with the Eagles. They haven't met since Baltimore's 30-28 win in Week 6 at Philadelphia in 2020. --Field Level MediaMAPUTO, Mozambique. (AP) — At least 6,000 inmates escaped from a high-security prison in Mozambique’s capital on Christmas Day after a rebellion, the country's police chief said, as widespread post-election riots and violence are roiling the country. Police chief Bernardino Rafael said 33 prisoners died and 15 others were injured during a confrontation with the security forces. The prisoners fled during violent protests that have seen police cars, stations and infrastructure destroyed after the country’s Constitutional Council confirmed the ruling Frelimo party as the winner of the Oct. 9 elections. The escape from the Maputo Central Prison, located 14 kilometers (9 miles) southwest of the capital, started around midday on Wednesday after “agitation” by a “group of subversive protesters” nearby, Rafael said. Some of the prisoners at the facility snatched weapons from the guards and started freeing other detainees. “A curious fact is that in that prison we had 29 convicted terrorists, who they released. We are worried, as a country, as Mozambicans, as members of the defense and security forces,” said Rafael. “They (protesters) were making noise, demanding that they be able to remove the prisoners who are there serving their sentences”, said Rafael, adding that the protests led to the collapse of a wall, allowing the prisoners to flee. He called on the escaped prisoners to surrender to authorities and for the population to be informed about the fugitives. Videos circulating on social media show the moment inmates left the prison, while other recordings reveal captures made by military personnel and prison guards. Many prisoners tried to hide in homes, but some were unsuccessful and ended up being detained again. In one video, a prisoner still with handcuffs on his right wrist says he was held n the disciplinary section of the prison and was released by other inmates.
NEW YORK , Dec. 3, 2024 /PRNewswire/ -- Consolidated Edison, Inc. (Con Edison) ED today announced the public offering of 7,000,000 of its common shares. In connection with the forward sale agreement described below, the forward counterparty (as defined below) has agreed to borrow from third parties and sell such shares to J.P. Morgan Securities LLC, which is acting as the underwriter in connection with the offering. The underwriter may offer the common shares in transactions on the New York Stock Exchange, in the over-the-counter-market or through negotiated transactions at either market prices or negotiated prices. Pursuant to the forward sale agreement, Con Edison expects to issue and deliver to J.P. Morgan Securities LLC or its affiliate (the "forward counterparty"), 7,000,000 of its common shares upon physical settlement of the forward sale agreement in exchange for cash proceeds per share equal to a forward price per share determined as provided in the forward sale agreement. Con Edison expects to use the cash proceeds it receives upon the full physical settlement of the forward sale agreement to invest in its subsidiaries for funding of their capital requirements and for its other general corporate purposes. Con Edison may, subject to certain conditions, elect cash settlement or net share settlement instead of physical settlement for all or a portion of its obligations under the forward sale agreement. Settlement of the forward sale agreement is expected to occur by December 31, 2025 ; however, the forward sale agreement may be settled earlier in whole or in part at Con Edison's option, subject to satisfaction of certain conditions. Con Edison will not receive any proceeds from the sale of the common shares sold by the forward counterparty to the underwriter. If Con Edison is required to issue and sell any top-up shares (as defined below) to the underwriter, Con Edison would receive proceeds from the sale of the top-up shares (and the number of shares subject to the forward sale agreement would be reduced accordingly). In the event that, in the forward counterparty's commercially reasonable judgment, the forward counterparty (or its affiliate) is unable to borrow and deliver for sale to the underwriter any common shares that it was to borrow and deliver for sale, or the forward counterparty (or its affiliate) would incur a stock loan cost greater than a specified rate to do so, Con Edison will issue and sell directly to the underwriter the number of common shares that the forward counterparty (or its affiliate) does not borrow and deliver for sale (the "top-up shares"). The offering is being made pursuant to Con Edison's effective shelf registration statement filed with the Securities and Exchange Commission (the "SEC"). The preliminary prospectus supplement and the base prospectus relating to the offering will be available on the SEC's website at http://www.sec.gov . Copies of the prospectus supplement and the base prospectus relating to the offering may be obtained from J.P. Morgan, c/o Broadridge Financial Solutions 1155 Long Island Avenue, Edgewood, New York 11717, Emails: prospectus-eq_fi@jpmchase.com and postsalemanualrequests@broadridge.com . This press release does not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any jurisdiction in which the offer, solicitation or sale of these securities would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. The offering of these securities will be made only by means of the prospectus and related prospectus supplement meeting the requirements of Section 10 of the Securities Act of 1933, as amended (the "Securities Act"). This press release contains forward-looking statements that are intended to qualify for the safe-harbor provisions of Section 27A of the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are statements of future expectations and not facts. Words such as "forecasts," "expects," "estimates," "anticipates," "intends," "believes," "plans," "will," "target," "guidance," "potential," "goal," "consider" and similar expressions identify forward-looking statements. The forward-looking statements reflect information available and assumptions at the time the statements are made, and accordingly speak only as of that time. Actual results or developments might differ materially from those included in the forward-looking statements because of various factors such as those identified in reports Con Edison has filed with the SEC, including, but not limited to: its subsidiaries are extensively regulated and are subject to substantial penalties; its utility subsidiaries' rate plans may not provide a reasonable return; it may be adversely affected by changes to the utility subsidiaries' rate plans; the failure of, or damage to, its subsidiaries' facilities could adversely affect it; a cyber attack could adversely affect it; the failure of processes and systems, the failure to retain and attract employees and contractors, and their negative performance could adversely affect it; it is exposed to risks from the environmental consequences of its subsidiaries' operations, including increased costs related to climate change; its ability to pay dividends or interest depends on dividends from its subsidiaries; changes to tax laws could adversely affect it; it requires access to capital markets to satisfy funding requirements; a disruption in the wholesale energy markets, increased commodity costs or failure by an energy supplier or customer could adversely affect it; it faces risks related to health epidemics and other outbreaks; its strategies may not be effective to address changes in the external business environment; it faces risks related to supply chain disruptions and inflation; and it also faces other risks that are beyond its control. This list of factors is not all-inclusive because it is not possible to predict all factors that could cause actual results or developments to differ from the forward-looking statements. Con Edison assumes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. Consolidated Edison, Inc. is one of the nation's largest investor-owned energy-delivery companies. The company provides a wide range of energy-related products and services to its customers through the following subsidiaries: Consolidated Edison Company of New York , Inc., a regulated utility providing electric, gas and steam service in New York City and Westchester County, New York ; Orange and Rockland Utilities, Inc., a regulated utility serving customers in a 1,300-square-mile-area in southeastern New York State and northern New Jersey ; and Con Edison Transmission, Inc., which through its subsidiaries, invests in electric transmission projects and manages, through joint ventures, both electric and gas assets. View original content to download multimedia: https://www.prnewswire.com/news-releases/con-edison-announces-common-share-offering-with-a-forward-component-302321645.html SOURCE Consolidated Edison, Inc. © 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Workday Appoints Liz Centoni to its Board of Directors
Solid Biosciences Added to the Nasdaq Biotechnology IndexNew Mexico man awarded $412 million medical malpractice payout for botched injections
UnitedHealth projects 2025 operating cash flow below estimatesAI harm is often behind the scenes and builds over timeIceland votes for new a parliament after coalition dissolved
- Previous: 23 superph
- Next: 99 superph